Pharmabiz22m
AstraZeneca, Daiichi Sankyo seek US FDA’s accelerated approval for datopotamab deruxtecan to treat advanced EGFR-mutated NSCLC
New results from a pooled analysis of patients with previously treated EGFR-mutated NSCLC in the TROPION-Lung05 and TROPION-Lung01 trials will be featured in a late-breaking presentation at the ...
MedPage Today20h
Year in Review: Early Breast Cancer
News in early breast cancer this year was marked by updated U.S. Preventive Services Task Force (USPSTF) screening ...
Mena FN20h
Curevac Announces Financial Results For The Third Quarter And First Nine Months Of 2024 And Provides Business Update
in patients with resected glioblastoma in September 2024 at the European Society for Medical Oncology (ESMO) Congress and in November at the Society for Immunotherapy of Cancer (SITC) and the Society ...
TMCnet22h
IO Biotech Reports Third Quarter 2024 Financial Results and Provides Business Highlights
evaluating IO102-IO103 in combination with pembrolizumab in the first-line treatment of patients with metastatic disease were presented at the 2024 European Society of Medical Oncology (ESMO) Congress ...
manilatimes22h
iTeos Reports Third Quarter 2024 Financial Results and Provides Business Updates
Pro forma cash and investment balance of $683.9 million as of September 30, 2024 expected to provide runway through 2027 across a number of impactful portfolio milestones. WATER ...